Evolution of prostate MRI: from multiparametric standard to less-is-better and different-is better strategies.
Rossano GiromettiLorenzo CereserFilippo BonatoChiara ZuianiPublished in: European radiology experimental (2019)
Multiparametric magnetic resonance imaging (mpMRI) has become the standard of care to achieve accurate and reproducible diagnosis of prostate cancer. However, mpMRI is quite demanding in terms of technical rigour, patient's tolerability and safety, expertise in interpretation, and costs. This paper reviews the main technical strategies proposed as less-is-better solutions for clinical practice (non-contrast biparametric MRI, reduction of acquisition time, abbreviated protocols, computer-aided diagnosis systems), discussing them in the light of the available evidence and of the concurrent evolution of Prostate Imaging Reporting and Data System (PI-RADS). We also summarised research results on those advanced techniques representing an alternative different-is-better line of the still ongoing evolution of prostate MRI (quantitative diffusion-weighted imaging, quantitative dynamic contrast enhancement, intravoxel incoherent motion, diffusion tensor imaging, diffusional kurtosis imaging, restriction spectrum imaging, radiomics analysis, hybrid positron emission tomography/MRI).
Keyphrases
- diffusion weighted imaging
- contrast enhanced
- magnetic resonance imaging
- prostate cancer
- computed tomography
- high resolution
- diffusion weighted
- positron emission tomography
- magnetic resonance
- radical prostatectomy
- benign prostatic hyperplasia
- clinical practice
- case report
- open label
- high speed
- pain management
- chronic pain
- pet ct
- emergency department
- randomized controlled trial
- quality improvement
- photodynamic therapy
- data analysis